Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
5.67
+0.13 (2.35%)
At close: Feb 21, 2025, 4:00 PM
5.77
+0.10 (1.76%)
After-hours: Feb 21, 2025, 5:20 PM EST
Phathom Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Phathom Pharmaceuticals stock have an average target of 23, with a low estimate of 12 and a high estimate of 28. The average target predicts an increase of 305.64% from the current stock price of 5.67.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 10, 2025.
Analyst Ratings
The average analyst rating for Phathom Pharmaceuticals stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +393.83% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +393.83% | Dec 12, 2024 |
| Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +393.83% | Dec 11, 2024 |
| Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +358.55% | Sep 13, 2024 |
| Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +358.55% | Sep 6, 2024 |
Financial Forecast
Revenue This Year
51.51M
from 682.00K
Increased by 7,453.23%
Revenue Next Year
168.13M
from 51.51M
Increased by 226.38%
EPS This Year
-5.71
from -3.93
EPS Next Year
-4.48
from -5.71
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 58.4M | 207.7M | 515.0M | |||
| Avg | 51.5M | 168.1M | 381.6M | |||
| Low | 44.4M | 134.5M | 268.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 8,460.1% | 303.2% | 206.3% | |||
| Avg | 7,453.2% | 226.4% | 127.0% | |||
| Low | 6,409.4% | 161.2% | 59.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -5.72 | -3.62 | -0.35 | |||
| Avg | -5.71 | -4.48 | -2.17 | |||
| Low | -5.63 | -5.94 | -2.85 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.